ASIC1, acid sensing ion channel subunit 1, 41

N. diseases: 52; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0007682
Disease: CNS disorder
CNS disorder
0.010 Biomarker group BEFREE The subtype ASIC1 is involved in various CNS diseases and therefore focusing on its specific functional properties will guide in drug design methods. 30124148 2019
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 Biomarker disease BEFREE Beneficial effect of mirtazapine on diabetes-induced hyperalgesia: involvement of TRPV1 and ASIC1 channels in the spinal cord and dorsal root ganglion. 30822229 2019
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.010 Biomarker group BEFREE Beneficial effect of mirtazapine on diabetes-induced hyperalgesia: involvement of TRPV1 and ASIC1 channels in the spinal cord and dorsal root ganglion. 30822229 2019
CUI: C0018790
Disease: Cardiac Arrest
Cardiac Arrest
0.010 Biomarker disease BEFREE Inhibition of central IL-6 and TNF-α also decreased ASIC1 in the hippocampus of CA rats. 31272354 2019
CUI: C0020429
Disease: Hyperalgesia
Hyperalgesia
0.010 Biomarker phenotype BEFREE Beneficial effect of mirtazapine on diabetes-induced hyperalgesia: involvement of TRPV1 and ASIC1 channels in the spinal cord and dorsal root ganglion. 30822229 2019
CUI: C0030193
Disease: Pain
Pain
0.010 Biomarker phenotype BEFREE Several types of acid-sensing ion channels (ASIC1 and ASIC3) were associated with disturbed neurogenesis and melatonin-regulated pain mechanism. 31340682 2019
CUI: C0013170
Disease: Drug habituation
Drug habituation
0.010 Biomarker phenotype BEFREE Olfactory behavior of wild-type (WT) and ASIC1-/- mice was evaluated by using three standard olfactory tests: (1) the buried food test, (2) the olfactory habituation test, and (3) the olfactory preference test. 28912013 2018
CUI: C0029124
Disease: Optic Atrophy
Optic Atrophy
0.010 Biomarker disease BEFREE Therefore, blockers of ASIC1 can be used as potential therapeutics in the treatment of optic nerve degeneration. 29111855 2018
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders
0.010 Biomarker group BEFREE These pharmacological data support the involvement of peripheral ASIC1-containing channels in migraine cutaneous allodynia as well as in its chronification. 30079481 2018
CUI: C0178782
Disease: Orofacial Pain
Orofacial Pain
0.010 Biomarker phenotype BEFREE KR has pharmacological potential for the treatment of acute orofacial pain and this effect is modulated by the opioid and nitrergic systems as well as TRPV1, TRPA1 and ASIC channels. 30257314 2018
CUI: C0267071
Disease: Oropharyngeal Dysphagia
Oropharyngeal Dysphagia
0.010 Biomarker disease BEFREE The aim of this study was to assess the expression and localization of TRPM8, ASIC1, and ASIC3 in human samples of the oropharynx to lay the basis for new pharmacological treatments for OD. 29971861 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.010 Biomarker phenotype BEFREE Our study is the first report of attenuating the malignant phenotype of GC in vitro and in vivo by suppressing ASIC1a, and suggests a novel approach to study the relationship between ASICs and GC cell migration and invasion. 29584803 2018
CUI: C1274924
Disease: Cutaneous allodynia
Cutaneous allodynia
0.010 Biomarker phenotype BEFREE These pharmacological data support the involvement of peripheral ASIC1-containing channels in migraine cutaneous allodynia as well as in its chronification. 30079481 2018
CUI: C2936719
Disease: Mechanical Allodynia
Mechanical Allodynia
0.010 Biomarker phenotype BEFREE Effects of systemic inhibitors of acid-sensing ion channels 1 (ASIC1) against acute and chronic mechanical allodynia in a rodent model of migraine. 30079481 2018
CUI: C2973725
Disease: Pulmonary arterial hypertension
Pulmonary arterial hypertension
0.010 Biomarker disease BEFREE They are involved in both HPV and pathological remodeling since their pharmacological blockade or genetic suppression of several of the Stim, Orai, TRP, or ASIC proteins in SOC or ROC complexes attenuate the calcium increase, the tension development, the pulmonary artery smooth muscle proliferation, and pulmonary arterial hypertension. 29867539 2018
Idiopathic pulmonary arterial hypertension
0.010 Biomarker disease BEFREE They are involved in both HPV and pathological remodeling since their pharmacological blockade or genetic suppression of several of the Stim, Orai, TRP, or ASIC proteins in SOC or ROC complexes attenuate the calcium increase, the tension development, the pulmonary artery smooth muscle proliferation, and pulmonary arterial hypertension. 29867539 2018
CUI: C0018834
Disease: Heartburn
Heartburn
0.010 Biomarker phenotype BEFREE Inhibition of ASIC1 and ASIC3 with siRNA or pharmacological inhibitor significantly decreased [Ca<sup>2+</sup>]i and its downstream RhoA during acidity and, thus, suppressed acidity-induced epithelial-mesenchymal transition (EMT) of pancreatic cancer cells. 28518134 2017
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.010 Biomarker group BEFREE ASIC1 knockdown extended the survival rate of animals and inhibited the tumor volume in the murine heterotopic xenograft model. 28111260 2017
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.010 Biomarker disease BEFREE ASIC1 promotes differentiation of neuroblastoma by negatively regulating Notch signaling pathway. 28030818 2017
Secondary malignant neoplasm of lung
0.010 Biomarker disease BEFREE Significantly, although without obvious effect on proliferation, knockdown of ASIC1 and ASIC3 in pancreatic cancer cells significantly suppresses liver and lung metastasis in xenograft model. 28518134 2017
CUI: C0158026
Disease: Monoarthritis
Monoarthritis
0.010 AlteredExpression disease BEFREE We examined the expression profile of ASICs and other genes in the amygdala in MoAr and sham animals, and found no variation of the expression of ASIC1a, which was confirmed at the protein level. 28321113 2017
CUI: C0184567
Disease: Acute onset pain
Acute onset pain
0.010 Biomarker phenotype BEFREE DEAB activity appears to involve the opioid system, TRPM8, and ASIC receptors, clearly showing that the DEAB alleviates acute pain in mice and suggesting the involvement of the TRPM8 and ASIC receptors and the opioid system in acute pain relief. 29099043 2017
CUI: C0596240
Disease: Cancer Pain
Cancer Pain
0.010 Biomarker phenotype BEFREE Our results suggest an analgesic effect of quetiapine in the CIBP animal model and implicate TRPV and ASICs as potential targets for cancer pain management. 28103434 2017
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.010 Biomarker disease BEFREE ASIC1 promotes differentiation of neuroblastoma by negatively regulating Notch signaling pathway. 28030818 2017
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.010 Biomarker disease BEFREE ASIC1 promotes differentiation of neuroblastoma by negatively regulating Notch signaling pathway. 28030818 2017